![]() |
|
|
Vol. 290, Issue 2, 535-542, August 1999
Department of Pharmacology, Pavlov Medical University, St. Petersburg, Russia (A.K., E.Z.); and Section of Molecular Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden (A.K., B.J., B.B.F.)
| |
Abstract |
|---|
|
|
|---|
Drug-naive DBA/2 mice were trained to self-administer cocaine (40 µg/kg/infusion) i.v. by nose poking. The number of nose-poke responses was higher in mice receiving response-contingent injections of cocaine (active group) than in yoked controls or in animals receiving response-contingent saline injections. Twenty-four hours after the training session (cocaine or saline self-administration), mice were injected i.p. with saline, cocaine, caffeine, 1,3-dipropyl-8-cyclopentyl xanthine (DPCPX), 8-cyclopentyl theophylline (8-CPT), 5-amino-7-(2-phenylethyl)2-(2-furyl)-pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261), or 9-chloro-2(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS 15943) and placed again in exactly the same operant boxes as during the training session but without response-contingent i.v. infusions. Saline injection elicited similar responding in animals from the active group and from the yoked control group. A low dose of cocaine (5 mg/kg) or caffeine (3 mg/kg), but not higher doses, produced greater responding in the active group than in the yoked control group during a single extinction trial. The adenosine A1-receptor antagonists DPCPX and 8-CPT and the nonselective antagonist CGS 15943 partially reproduced the effect of a low dose of caffeine on the cocaine-associated behavior in a dose-dependent manner and did not alter the nose-poke activity of yoked control mice in the extinction experiment. In contrast, the adenosine A2A antagonist SCH 58261, in doses above 1 mg/kg, reduced nose-poke activity equally in active and yoked control animals. This confirms that a drug from a different pharmacological class (adenosine-receptor antagonist) can induce behavior changes similar to the effects of the original self-administered drug (indirect dopamine-receptor agonist). The data also suggest that the effects of caffeine on cocaine-seeking behavior might be related to interaction with adenosine A1 receptors, but not A2A receptors.
| |
Introduction |
|---|
|
|
|---|
Cocaine-dependent
individuals tend to relapse into cocaine use even after long periods of
abstinence. It is important to find factors that contribute to such a
relapse. Animal studies have shown that drug-seeking behavior can be
elicited not only by a low dose of the original self-administered drug
(Gerber and Stretch, 1975
; de Wit and Stewart, 1981
; Stewart and Wise,
1992
; Self et al., 1996
), but also by drugs from pharmacological groups
other than that of the original self-administered drug (Slikker et al., 1984
).
Previously, it was shown that caffeine reinstated responding during an
extinction phase in rats trained to self-administer cocaine (Worley et
al., 1994
; Schenk et al., 1996
) or potentiated cocaine effects on the
reinstatement of self-administration behavior (Self et al., 1996
). The
nature of this cue is not understood presently. Caffeine does not
generalize well to cocaine in a drug-discrimination paradigm, and it is
poorly self-administered (Griffiths and Woodson, 1988
; Gauvin et al.,
1990
). However, cocaine substituted for the caffeine-discriminative
stimulus in rats trained to discriminate caffeine from saline
(Holtzman, 1986
). Thus, how caffeine and cocaine can substitute for
each other, and to what extent, remains to be determined.
Of all of the known primary biochemical mechanisms of action of
caffeine, only antagonism of adenosine effects on adenosine A1 and A2A receptors is
known to be important at concentrations of caffeine that
produce behavioral stimulation (see Fredholm, 1995
). Adenosine
A1 receptors are widely distributed in the brain (Johansson et al., 1993
) and regulate the release of several
neurotransmitters (Fredholm and Dunwiddie, 1988
). In contrast,
adenosine A2A receptors are largely restricted to
neurons that release
-aminobutyric acid that also express
dopamine D2 receptors (Fink et al., 1992
; Svenningsson et al., 1997a
), and there is a functionally important negative interaction between adenosine A2A and
dopamine D2 receptors (see Ferré et al.
1997
). Perhaps secondarily to its primary effects, caffeine also
influences and interacts with a host of transmitter systems in the
brain (see Daly, 1993
).
Recently, it was shown that an agonist at dopamine
D2 receptors, but not one at
D1 receptors, could reinstate
cocaine-seeking behavior (Self et al., 1996
). Given that
D2 and A2A receptors are
colocalized, that they are mutually antagonistic (Ongini and Fredholm,
1996
; Ferré et al., 1997
), and that an
A2A-receptor antagonist can mimic the stimulation
of motor behavior produced by a D2-receptor
agonist (Svenningsson et al., 1995
), it seemed possible that the
ability of caffeine to reinstate the extinguished cocaine-seeking
behavior is mainly associated with its ability to block
A2A receptors.
To test this possibility, we used a technique of the
extinction of cocaine-associated behavior based on a model of
one-session initiation of i.v. cocaine self-administration in naive
mice (Kuzmin et al., 1997
). With this model, we tested the ability of
cocaine and caffeine to prevent the extinction of cocaine
reward-associated responding in mice withdrawn from contingent
reinforcing infusions of cocaine. Also, we examined the ability of
selective adenosine A1-receptor antagonists,
1,3-dipropyl-8-cyclopentyl xanthine (DPCPX) and 8-cyclopentyl
theophylline (8-CPT), a selective A2A-receptor antagonist,
5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo-[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine (SCH 58261; see Ongini and Fredholm, 1996
), and a nonselective, nonxanthine, adenosine-receptor antagonist,
9-chloro-2(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine (CGS
15943) to mimic the effect of caffeine.
| |
Materials and Methods |
|---|
|
|
|---|
Animals. All experiments were carried out on male DBA/2 mice (18-22 g). Animals were obtained from the breeding farms in Rappolovo, Russia and Bomholtgård, Denmark and kept under standard laboratory conditions with unlimited access to food and water. They were housed 12 mice per cage in a light-controlled room (12 h light/dark cycle; light on at 10:00 AM) at 21°C and 60% humidity. The experiments were approved by the respective regional animal ethics boards.
Drugs. Caffeine (as free base; Sigma Chemical Co., St. Louis, MO) and cocaine (as hydrochloride; Sigma Chemical Co.) were dissolved in warm saline and injected i.p. just before the experiment. SCH 58261 (a gift from Dr. Ennio Ongini, Schering-Plough, Milan, Italy), CGS 15943 (Research Biochemicals International, Natick, MA) and DPCPX (Research Biochemicals International) were dissolved in dimethyl sulfoxide (DMSO), and stock solutions were diluted in saline so that the final concentration of DMSO was 20% (v/v). 8-CPT (Research Biochemicals International) was dissolved in 0.01 N NaOH and the pH of the solution was adjusted to 7.2 with 0.01 N HCl. Cocaine HCl for i.v. self-administration was dissolved in saline and the pH of the solution was adjusted to 7.2 with 0.01 N NaOH. Doses of cocaine refer to the salt.
Intravenous Self-Administration Method.
The model of
one-session initiation of i.v. self-administration of cocaine was used
(40 µg/kg/infusion; 1.6 µl per infusion; fixed ratio = 1;
naive mice; Kuzmin et al., 1997
). This unit dose was chosen on the
basis of preliminary testing in the range from 10 to 80 µg/kg/infusion. Mice were tested in pairs in cages (8 × 8 × 8 cm) that had a frontal hole (1.5 cm) for nose poking fitted with
infrared sensors (3 mm into the hole from the inner surface of the
cage) interfaced to an operating computer that controlled the automatic
syringe pump. Mice were partially immobilized by fixing their tails
with adhesive tape to the horizontal surface. The tails protruded
through a vertical slot in the back wall of the box.
Extinction of Cocaine Reward-Associated Responding. On day 2, extinction sessions were carried out. Just before placement into boxes, both active and yoked control mice were injected i.p. (1 ml/kg) with saline or one of the compounds investigated: cocaine HCl (2.5-20 mg/kg); caffeine (3-30 mg/kg); CGS 15943 (1.25-5 mg/kg); SCH 58261 (0.312-2.5 mg/kg); DPCPX (1.25-5.0 mg/kg); or 8-CPT (5-20 mg/kg). There were six pairs in the treatment groups except in the groups given cocaine and caffeine treatment (n = 8). After the injection, pairs of mice were placed into exactly the same experimental boxes and partially immobilized as in the initiation experiments (day 1), but the needles were not introduced and cocaine infusions were not activated. As in the initiation session, the number of nose pokes of each mouse in the pair was counted and analyzed.
Data Analysis and Statistics. The number of nose pokes for active and yoked control mice in each treatment group was analyzed with two-way ANOVA; mode (active mice versus yoked control mice) and dose (saline/vehicle and drug treatments) were the independent factors. Next, paired comparison (two-tailed Student's t test) was performed to compare active and yoked control activity within each group of drug-injected animals and nose-poke activity in active and yoked control animals between the drug-treated group and a saline/vehicle-treated group. The whole study was designed as a between-subjects (independent groups) experiment (i.e., each treatment we describe was done on a single set of animals).
Next, the r criterion was analyzed in a similar way: one-way ANOVA for the r criteria (with drug treatment as an independent factor), followed by paired comparison of the r criteria (two-tailed Student's t test) in an extinction experiment with corresponding ratios in the acquisition experiment and the extinction ratio in the control group (treated with saline/vehicle).| |
Results |
|---|
|
|
|---|
Initiation of Cocaine/Saline Self-Administration. The initial nose-poke activities (in a 10-min trial without infusions) did not differ significantly between the different groups of animals. The mean number of nose-poke responses in the various groups ranged from 23.88 ± 14.13 to 31 ± 12.87 during 10 min of testing (lowest and highest levels for different groups; mean ± S.E.M.). However, it is important to note that the difference in nose-poke activity between individual pairs was significant (from 16 to 88 in 10 min; lowest and highest activity in pairs). Two-way ANOVA showed no difference between treatment groups (p = .49) or between active and yoked control mouse subgroups (p = .86), and there was no interaction between group and subgroup factors. From this, it can be concluded that the matching between and within experimental groups was successful. Thus, any reinforcing action of the contingent infusions of the drug solution was expected to result in a larger number of nose pokes by the active mouse than by the yoked control.
Cocaine (40 µg/kg/infusion), when made contingent to the nose pokes of one animal in the pair, selectively and significantly increased the operant responses of active animals (t = 13.55; p < .001; 276 degrees of freedom), whereas the responses of the yoked control animals remained unchanged and did not differ from the activity of the control animals in groups with saline self-administration. This translates into a highly significant (p < .01) increase of the r criterion (i.e., the logarithm of the ratio of nose-poke responses in treatment versus control group; see Materials and Methods) in mice given cocaine on day 1 (0.27 ± 0.01, 148 selected pairs) as compared with that in mice offered saline self-administration (
0.02 ± 0.01; 32 selected pairs). This was interpreted as a
strong reinforcing effect of this particular unit dose of cocaine. In addition, the results show that a 30-min experimental session with the
nose-poke operant procedure is sufficient for mice to acquire cocaine
self-administration behavior. For the extinction experiments, only
pairs of mice that reached the criterion for the acquisition of cocaine
self-administration were used (see Materials and Methods).
Extinction.
On day 2, mice were given i.p. injections of
different drugs or saline/vehicle and placed into exactly the same
experimental boxes as in the initiation experiment. In the groups
injected with saline/vehicle, the number of nose pokes was not
significantly different between active and yoked control mice (see
Figs. 1-3). The ratio between the
response rate in the two paired mice was close to 1 and, hence, the
r criterion did not differ from 0. This was interpreted as
the extinction of the behavior acquired on day 1 in the absence of
response-contingent cocaine infusions. Injection of the vehicle for
adenosine antagonists (20% DMSO) produced a parallel decrease in nose
pokes in both active and yoked control mice as compared with
saline-treated animals. However, the r criterion remained on
the same level after vehicle treatment as after saline treatment.
|
Effects of Cocaine in the Extinction Phase. Injection of cocaine had a dose-dependent influence on the operant pattern in mice trained to self-administer cocaine (Fig. 1). Administration of cocaine at the dose of 5.0 mg/kg increased specifically the nose-poking response of the active animals that had learned to self-administer cocaine on day 1 (p < .05 as compared with the saline-treated group). ANOVA revealed a significant effect of cocaine on the number of nose pokes in the active mice (F(4,29) = 4.31; p = .007; n = 8 animals per group). However, this effect of cocaine (5.0 mg/kg) was not seen in the active animals trained for saline self-administration on day 1 (data not shown) or in yoked control animals that were trained with either cocaine or saline infusion on day 1. With the higher doses of cocaine (10 and 20 mg/kg), there were no significant differences in nose-poking activity between the animals in the pair.
ANOVA also showed a significant influence of cocaine dose on r criteria (F(4,29) = 8.79; p = .00008). Paired comparison revealed a significant difference between r criteria in the initiation experiment versus the extinction experiment in the groups injected with saline (p = .002) or the two highest doses of cocaine (10 mg/kg, p = .008; 20 mg/kg, p = .00001). In groups injected with 2.5 or 5.0 mg/kg cocaine, the r criterion in the extinction experiment did not differ significantly from that in the initiation experiment. However, it was only in the group injected with 5.0 mg/kg cocaine that the r criterion during extinction differed significantly from that in the group injected with saline (p < .05). Of special importance is the fact that cocaine (5.0 mg/kg) did not increase the value of the r criterion in mice that had been trained to self-administer saline during the initiation experiment.Effects of Caffeine in the Extinction Phase. ANOVA failed to reveal a significant effect of caffeine treatment on the number of nose pokes in groups. However, there was a significant influence of caffeine dose on the level of the r criterion in the extinction experiment (F(3,26) = 7.04; p = .001; n = 8 animals per group) with a significant increase of the r criterion (p < .01, compared with the saline-injected group) in the group injected with caffeine (3 mg/kg). Paired comparison revealed a significant difference between r criteria in the initiation versus the extinction experiment in the groups injected with saline (p = .002) or with caffeine at the doses of 10 mg/kg (p = .0002) and 30 mg/kg (p = .002; Fig. 1, bottom). There was no difference between the r criteria in initiation and extinction sessions in the group treated with caffeine at the dose of 3 mg/kg. Thus, it was concluded that i.p. administration of caffeine at a dose of 3 mg/kg maintained the cocaine-oriented pattern of behavior in mice in the absence of contingent, reinforcing cocaine infusions, and prevented the extinction of cocaine-oriented behavior, whereas higher doses of caffeine lacked this effect. To find the reason for these effects, paired comparison of the nose pokes in particular groups was performed. Among the active mice trained to self-administer cocaine, those injected with caffeine (3 mg/kg) exhibited more nose-poke responses than did those injected with saline (p = .05; Fig. 1). No such difference was seen in active mice trained for saline self-administration or in either of the yoked control groups. The highest dose of caffeine (30 mg/kg) increased responding in both active mice and yoked controls, but the effect did not reach statistical significance (p = .08). Thus, caffeine at the low dose (3 mg/kg) tended to increase specifically nose-poke responses of the active animals that had learned to self-administer cocaine on day 1.
Effects of the Nonselective Adenosine-Receptor Antagonist CGS
15943 in the Extinction Phase.
First, we examined whether the
effect of caffeine could be reproduced by CGS 15943, a structurally
unrelated antagonist, at adenosine A1 and
A2A receptors. CGS 15943 is approximately
1000-fold more potent than caffeine at both adenosine
A1 and A2A receptors (see
Ongini and Fredholm, 1996
). However, it is much less water-soluble and,
hence, its apparent volume of distribution is much higher. For this
reason, it must be given in vivo in doses close to those of caffeine.
As seen in Fig. 2, in none of the CGS
15943-treated groups (6 animals per group) was the r
criterion different from that obtained in the initiation experiments,
whereas such a difference was observed in the vehicle-treated group.
Although ANOVA failed to show a significant influence of the drug on
the nose-poke activity in the extinction experiment, we tested whether
the increase in the r criterion with the highest dose of CGS
15943 was because of an increase in nose-poke responding in active mice
or because of a decrease in activity in yoked control mice. The former
was the case (p < .05; active and yoked control groups
were compared with Student's t test). Thus, we concluded
that CGS 15943 tends to prevent the extinction of the cocaine-oriented
behavior.
|
Effects of the Adenosine A2A-Receptor Selective
Antagonist SCH 58261 in the Extinction Phase.
Next, we
examined the effect of a highly selective adenosine
A2A-receptor antagonist, SCH 58261, which is
structurally related to CGS 15943 (see Ongini and Fredholm, 1996
). This
compound is at least as potent as CGS 15943 as an antagonist at
A2A receptors, but at least 100 times less potent
at A1 receptors. Therefore, it was given in doses
similar to those of CGS 15943. As seen in Fig. 2, lower doses of this
compound had little effect on nose-poke responding, whereas higher
doses produced a marked decrease. ANOVA revealed a significant effect
of SCH 58261 injection on nose-poke responses in both active and yoked
control mice (F(4,25) = 22.5; p < .0005 and F(2,25) = 20.5; p < .0005, respectively; 6 animals per group).
There was a significant reduction (compared with vehicle-injected group) of the operant activity in the groups injected with SCH 58261 at
doses of 1.25 or 2.5 mg/kg (p < .01 for both doses). Treatment with 0.312 and 0.625 mg/kg had no effect on operant responses
in either active or yoked control mice (comparison with vehicle-treated
group). ANOVA also failed to reveal any significant effect of SCH 58261 on the r criteria in the extinction experiment. Paired
comparison of the levels of r criteria in the initiation versus the extinction experiments revealed that in all of the groups
injected with SCH 58261, the r criteria in the extinction experiments differed significantly from those in the initiation experiments. Thus, at none of the doses used did the selective adenosine A2A-receptor antagonist SCH 58261 prevent the extinction of cocaine-associated behavior.
Effects of the Adenosine A1 Receptor Selective
Antagonists DPCPX and 8-CPT in the Extinction Phase.
DPCPX is
slightly (about 3-fold) more potent than CGS 15943 on adenosine
A1 receptors, but almost 1000-fold less potent
than CGS 15943 at A2A receptors (see Ongini and
Fredholm, 1996
). Because the physicochemical properties of the two
compounds are similar, the doses used were also similar. The results of
experiments with DPCPX are presented in Fig.
3. ANOVA revealed significant differences between nose-poke responses in active and yoked control animals after
treatment with DPCPX (F(1,40) = 5.68;
p = .02; 6 animals per group), although the effect was
not dependent on the dose of DPCPX administered. Subsequent paired
comparison showed that at 5.0 mg/kg DPCPX, there was a significant
increase in the active group of mice (p = .04, comparison with the vehicle-treated group; p = .005, comparison with the corresponding yoked control group).
|
| |
Discussion |
|---|
|
|
|---|
This study shows that the initiation and the extinction of
cocaine-related behavior can be studied not only in rats, but also in
mice. A single, 30-min session in mice established self-administration of cocaine by means of directed nose pokes. This behavior was rapidly
extinguished in mice that received only saline/vehicle injections
during testing on a subsequent day. However, an i.p. injection of
cocaine at 5.0 mg/kg, a dose known to exert a reinforcing effect in a
conditioned place-preference paradigm in mice (Kuzmin et al., 1997
),
was able to stabilize the higher level of nose-poke activity in active
animals compared with the yoked control animals even when withdrawn
from the contingent cocaine infusions. The ability of cocaine to
effectively maintain cocaine-oriented behavior in the absence of
response-contingent injections of cocaine was not surprising because
others have shown that noncontingent administration of the
self-administered drug produces potent reinstatement of extinguished
drug-taking behavior (Gerber and Stretch, 1975
; de Wit and Stewart,
1981
; Slikker et al., 1984
; Self et al., 1996
). Conversely, the highest
dose of cocaine used in the present study (20 mg/kg), a dose that does
not induce conditioned place preference in mice (Kuzmin et al., 1997
),
lacked a priming effect during the extinction session. Thus, it can be
speculated that only reinforcing doses of the drugs are able to prevent
an extinction of drug-related behavior.
In our experiments, caffeine at the dose of 3 mg/kg i.p. also
effectively prevented the extinction of a cocaine-induced operant pattern. This finding confirms and extends previous data showing the
ability of caffeine to reinstate cocaine-seeking behavior in rats
(Worley et al., 1994
; Schenk et al., 1996
). However, Self and coworkers
(Self et al., 1996
) found that caffeine at the dose we used for this
study (3 mg/kg) lacked appreciable priming ability, whereas caffeine at
10 mg/kg tended to enhance cocaine priming. A probable explanation is
that in our mouse strain, the caffeine dose-response curve is slightly
shifted to the left compared with the rat strain used by Self and
coworkers (Self et al., 1996
), but there also are differences in
the experimental procedure. Whereas in our study there was a 24-h delay
after the cocaine self-administration session, in the cited study, the
extinction and the effects of priming caffeine injections were studied
2 to 4 h after the cocaine self-administration session.
Whereas the lower dose (3 mg/kg) of caffeine had a clear-cut priming
effect, a high dose (30 mg/kg) of caffeine induced an increase in nose
poking in both active and yoked control mice, but this activation was
not selective and lacks priming effect, according to the r
criteria. Because caffeine has a biphasic reinforcing/aversive activity
depending on the dose used (Brockwell et al., 1991
), the dose of 30 mg/kg in mice might have some aversive properties. In fact, our
preliminary experiments with the aid of the conditioned place-preference technique also showed that whereas caffeine at the
dose of 3 mg/kg produced conditioned place-preference in mice, the dose
of 30 mg/kg produced a strong place-aversion reaction (A.K.,
unpublished observation).
The ability of a low dose of caffeine to prevent the extinction of a
cocaine-related behavior cannot be explained simply by its psychomotor
stimulant properties (Schenk et al., 1989
) because an increased
responding was observed only in active animals and not in the yoked
control mice. Thus, the effect of caffeine is related to an association
of the operant responses with cocaine infusions on day 1 of the
experiment. Moreover, it has been shown previously that the
motor-activating effect of caffeine is not correlated with its ability
to reinstate cocaine-associated responding (Schenk et al., 1989
), and
that with repeated administration, the effectiveness of a dose of
caffeine in increasing motor activity remains unchanged, whereas its
ability to reinstate cocaine-associated responding decreases (Schenk et
al., 1996
).
It is important to note that the nose-poke activity does not
mirror the general motor activity in mice. In fact, administration of
high doses of cocaine (Kuzmin et al., 1997
) that produce definite stimulatory effect usually resulted in a decrease in the number of nose
pokes in the technique used. This gives a unique opportunity to study
selectively the reinforcing effects of drugs because the increase in
nose-poke activity was found only in mice that actively self-administer
cocaine and not in animals from the yoked control group.
It is possible that some component of the effects of caffeine can
modify cocaine-sensitive systems, possibly by the activation of the
central dopaminergic systems (Ferré et al., 1991
; Garrett and
Holtzman, 1994
). As mentioned, it is generally believed that a major
primary neurochemical effect of caffeine is the blockade of adenosine
receptors (Daly, 1993
; Fredholm, 1995
), and this effect has been
demonstrated as critical for the acute stimulant effects of caffeine
(Kaplan et al., 1989
; Holtzman, 1991
). It also has been shown that
activation of adenosine receptors can antagonize the effects of
dopamine at both D1 and D2
receptors (see Ferré et al., 1997
). There is a high density of
A2A receptors in the accumbens nucleus (Parkinson
and Fredholm, 1990
; Johansson et al., 1997
), where they can modulate
striatal dopaminergic neurotransmission. Furthermore, there are
antagonistic adenosine A2A-dopamine
D2 receptor interactions: activation of adenosine
A2A receptors decreases both the affinity of
dopamine D2 receptors and the signal transduction from dopamine D2 receptors to the guanine
nucleotide-binding protein (see Ferré et al., 1997
). The finding
that a dopamine D2 agonist, but not a dopamine
D1 agonist, reinstated cocaine-seeking behavior in rats (Self et al., 1996
) raised the possibility that
A2A-receptor antagonism in this terminal region
of the mesolimbic dopamine system underlies the reinstatement effects
produced by caffeine. Therefore, it was surprising that in our study,
the selective adenosine A2A antagonist could not
exhibit the same behavioral effect as a low dose of caffeine in the
extinction experiment despite the fact that this dose of the antagonist
can mimic the stimulatory effect of caffeine on motor behavior in rats
(Bertolli et al., 1996
; Pinna et al., 1996
). In fact, the
A2A-receptor antagonist caused a dose-dependent
decrease in nose-poke responses in both active and yoked control mice
and actually decreased the difference between them. In contrast, the
drugs that inhibit adenosine A1 receptors (i.e.,
DPCPX, CGS 15943, and, to a lesser extent, certain doses of 8-CPT) did
prevent, or tended to prevent, the extinction of cocaine-induced
behavior and maintained cocaine-associated responses in active mice on
a higher level than the responses of the yoked control mice.
A critically important question is whether the present results
are confounded by behavioral activation unrelated to cocaine seeking.
It can be argued that a nonspecific motor stimulation might enhance any
drug-related activity. This can only be partially controlled for by
yoked controls for the initiation of such behaviors, and it would be
particularly important if drug-induced activity persists at the time of
the experiment. Unpublished experiments with the present method show
that drug-related behavior is lost 10 to 20 min after the beginning of
the extinction session and that the level of activity remaining is not
different from that observed during a second or third extinction
session (48 or 72 h after initiation; A.K., E.E.Z., unpublished
data). Thus, the present method is, in this respect, not
significantly different from other methods used to study reinstatement.
Of course, it also could be argued that a motor stimulant would be able
to induce an activity that the animal has learned to perform
previously, even if that activity is not overt under basal conditions.
This is true, and we have not been able to control for this. However, the same problem occurs in every method for the study of reinstatement. There is, finally, one important finding from a previous study from our
laboratory that provides strong evidence against nonspecific motor
stimulation being the explanation for the major finding in our study.
Svenningsson and coworkers (Svenningson et al., 1997b
) showed that
DPCPX, the adenosine A1 antagonist that enhanced cocaine-seeking behavior in the present study, is not a motor stimulant, but actually tended to reduce locomotor activity.
Conversely, SCH 58261, which did not enhance cocaine-seeking behavior,
acted as a motor stimulant in that study. For all of these reasons, we
feel that nonspecific motor activation cannot explain the effects of
A1- and A2A-receptor
antagonists on cocaine-associated responding.
Adenosine A1 receptors have a widespread
distribution in the brain of most species (Fastbom et al., 1987
) and
are present in the nucleus accumbens, where they selectively counteract
responses to dopamine D1-receptor agonists
(Ferré et al., 1996
). In addition, adenosine
A1 receptors are located on the nerve terminals
of several types of neurons and inhibit the release of many
neurotransmitters (Fredholm and Dunwiddie, 1988
). Thus, an adenosine
A1 antagonist might increase the release of
endogenous dopamine (Stoner et al., 1988
), which is known to activate
dopamine receptors. Furthermore, adenosine A1
antagonists enhance signaling via such receptors (see Ferré et
al., 1996
). Such activation of dopaminergic transmission is known to be
part of the response to cocaine (Self and Nestler, 1995
). However,
recent findings have shown that reinstatement of cocaine-associated
behavior by cocaine priming does not correlate with the dopaminergic
neurotransmission in the accumbens nucleus (Neisewander et al., 1996
).
Furthermore, as noted above, a D1 agonist did not
reinstate cocaine-seeking behavior (Self et al., 1996
), although
D1 agonists were shown to maintain
self-administration behavior in rats (Weed et al., 1997
). Thus, the
schemes for explaining the actions of caffeine as well as selective
adenosine-receptor antagonists in terms of interactions with known
mechanisms involving dopamine receptors, schemes that work very well in
explaining the actions of these compounds on motor behavior (see
Ferré et al., 1997
), break down when trying to explain the
effects of these drugs in the extinction model of cocaine-seeking
behavior. Consequently, the mechanism of the maintenance of
drug-seeking behavior also must incorporate other neurotransmitter
systems and probably other neuronal circuits (Koob and Le Moal, 1997
).
It also might be speculated that the receptors involved in
reinforcement (D1 for cocaine and, possibly,
A2A for caffeine) are different from the
receptors involved in the processes of extinction and reinstatement
(D2 for cocaine and A1 for caffeine).
In summary, the present results show that a mouse model can be successfully used to study the mechanisms of the extinction of drug-seeking behavior during withdrawal from the response-contingent reinforcement. Given the increasing availability of genetically modified mouse strains, this type of experimental model might prove valuable in future studies of the genetic mechanisms involved in establishment, maintenance, extinction, and reinstatement of drug-seeking behavior. With this model, we demonstrated a clear-cut biphasic effect on the extinction of cocaine-seeking behavior when using both the self-administered drug (cocaine) and a drug from a completely different drug class (caffeine). Finally, low, behaviorally stimulant doses of caffeine can prevent the extinction of cocaine-seeking behavior, possibly via the blockade of A1 adenosine receptors.
| |
Acknowledgment |
|---|
We thank Dr. Ennio Ongini at the Schering-Plough pharmaceutical company in Milan for the gift of SCH 58261.
| |
Footnotes |
|---|
Accepted for publication April 22, 1999.
Received for publication October 7, 1998.
1 This work was supported by Physiological Effects of Coffee Committee (PEC), Swedish Medical Research Council (Projects 2553 and 12587), Socialstyrelsens Fonder, the Åke Wiberg Foundation, Magn. Bergvall Foundation, O. E. and Edla Johansson Scientific Foundation, Syskonen Svenssons Fund for Medical Research, and Fredrik and Ingrid Thuring Foundation. A. K. received visiting scientist support from the Karolinska Institute and from the Royal Swedish Academy of Sciences. B. J. was supported by a grant from the Brain Fund.
Send reprint requests to: Dr. Bertil B. Fredholm, Section of Molecular Neuropharmacology, Department of Physiology and Pharmacology, Karolinska Institute, S-171 77 Stockholm, Sweden. E-mail: Bertil.Fredholm{at}fyfa.ki.se
| |
Abbreviations |
|---|
DPCPX, 1,3-dipropyl-8-cyclopentyl xanthine; 8-CPT, 8-cyclopentyl theophylline; SCH 58261, 5-amino-7-(2-phenylethyl)-2-(2-furyl)pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine; CGS 15943, 9-chloro-2(2-furyl)[1,2,4]triazolo[1,5-c]quinazolin-5-amine; DMSO, dimethyl sulfoxide.
| |
References |
|---|
|
|
|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||